New York, May 18, 2016 -- Moody's Investors Service affirmed the ratings of Gilead Sciences, Inc., including the A3 senior unsecured ratings. At the same time, Moody's revised the rating outlook to stable from positive.

Vollständigen Artikel bei Moodys lesen